Eliem Therapeutics, Inc.
NASDAQ: ELYM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Aoife M. Brennan BAO, BCh, MB, MMSc
- Employees
- 9
- Headquarters
- Redmond, United States
- IPO year
- 2021
- Market cap
- $342.7M
- Website
- https://www.eliemtx.com
Loading ELYM…
Loading profile data…Frequently asked questions about ELYM
What does Eliem Therapeutics, Inc. (ELYM) do?
Eliem Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing therapeutic solutions for conditions characterized by abnormal neuronal excitability. The company aims to fulfill significant unmet medical needs in areas such as chronic pain management, neuropsychiatric illnesses, epilepsy, and other disorders affecting the c...
Where does ELYM trade?
Eliem Therapeutics, Inc. (ELYM) trades on the NASDAQ Global Market.
What sector is ELYM in?
Eliem Therapeutics, Inc. (ELYM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Eliem Therapeutics, Inc.?
Aoife M. Brennan BAO, BCh, MB, MMSc is the chief executive officer of Eliem Therapeutics, Inc. (ELYM).
Where is Eliem Therapeutics, Inc. headquartered?
Eliem Therapeutics, Inc. is headquartered in United States.
Does ELYM pay a dividend?
Eliem Therapeutics, Inc. (ELYM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELYM go public?
Eliem Therapeutics, Inc. (ELYM) completed its initial public offering in 2021.